Status:

WITHDRAWN

A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder

Lead Sponsor:

TO Pharmaceuticals

Conditions:

Autistic Disorder

Eligibility:

All Genders

2-8 years

Phase:

PHASE2

Brief Summary

This single center, double-blinded, randomized, placebo-controlled crossover trial will assess the efficacy and safety of extraction of cannabis flowers dissolved in olive oil (30% CBD and 1.5% Δ9-THC...

Detailed Description

Visit 1 - Screening and Enrollment The screening and enrollment procedures will take place at the Preschool Psychiatric Unit in Soroka University Medical Center (SUMC). Parents of children who meet al...

Eligibility Criteria

Inclusion

  • Signed informed consent
  • Children ages two to eight years old with a documented diagnosis of ASD.
  • Children with a previous report of behavioral issues characterized by aggression, anxiety, restlessness, sleep disturbances and/or self-harm, all as a part of the ASD, as documented in previous clinical estimation and examination.
  • Hebrew speaking and reading.

Exclusion

  • Children that are treated with cannabis, anti-psychotic drugs or stimulants.
  • Children with a comorbidity of heart, liver, kidney or hematologic disease.
  • Children that are treated with one of the following drugs: Astemizole, Cisapride, Pimozide or Terfenadine.
  • Children that suffer from epilepsy
  • Children which themselves or a first-degree family member suffer from psychosis and/or another mental illness.
  • Children in any condition in which the investigator is of the opinion that participating in the study is not the best option for them.
  • Children who underwent surgery during the 30 days prior to the trial.
  • Children that are participating in another trial which includes any intervention.

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05413187

Start Date

September 1 2020

End Date

September 1 2022

Last Update

June 9 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Soroka University Medical Center

Beersheba, Israel, 8410101

A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder | DecenTrialz